Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Cesare Gridelli

Showing results (1-10 of 357) with videos related to

Pageof 36
Sort By:
Lung Cancer (Amsterdam, Netherlands)|December 7, 2002
Chemotherapy of non-small cell lung cancer in the elderlyCesare Gridelli
Current Opinion in Oncology|November 30, 2011
Personalized medicine in the treatment of advanced nonsmall cell lung cancer: step-by-step progressCesare Gridelli
Current Opinion in Oncology|February 11, 2011
First-line treatment for advanced nonsmall cell lung cancer harboring activating epidermal growth factor receptor mutation: epidermal growth factor receptor tyrosine kinase inhibitors or chemotherapy?Cesare Gridelli
Current Opinion in Oncology|April 13, 2004
Targeted therapies in the treatment of non small cell lung cancer: reality and hopesCesare Gridelli
Drugs & Aging|October 21, 2004
Same old story? Do we need to modify our supportive care treatment of elderly cancer patients? Focus on antiemeticsCesare Gridelli
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 1, 2008
Treatment of advanced non small-cell lung cancer in the elderly: from best supportive care to the combination of platin-based chemotherapy and targeted therapiesCesare Gridelli
Current Opinion in Oncology|February 28, 2008
Targeted therapy developments in the treatment of non-small cell lung cancer: a promising but long and winding roadCesare Gridelli
Nature Reviews. Clinical Oncology|July 25, 2013
Lung cancer: Defining standard of care for performance status 2--don't rushCesare Gridelli
The Oncologist|January 18, 2007
The use of bisphosphonates in elderly cancer patientsCesare Gridelli
Nature Clinical Practice. Oncology|March 16, 2007
Does palliative chemotherapy beyond three courses benefit patients with non-small-cell lung cancer?Cesare Gridelli
Pageof 36

Showing results (1-10 of 357) with videos related to

Sort By:
Pageof 36
Lung Cancer (Amsterdam, Netherlands)|December 7, 2002
Chemotherapy of non-small cell lung cancer in the elderlyCesare Gridelli
Current Opinion in Oncology|November 30, 2011
Personalized medicine in the treatment of advanced nonsmall cell lung cancer: step-by-step progressCesare Gridelli
Current Opinion in Oncology|February 11, 2011
First-line treatment for advanced nonsmall cell lung cancer harboring activating epidermal growth factor receptor mutation: epidermal growth factor receptor tyrosine kinase inhibitors or chemotherapy?Cesare Gridelli
Current Opinion in Oncology|April 13, 2004
Targeted therapies in the treatment of non small cell lung cancer: reality and hopesCesare Gridelli
Drugs & Aging|October 21, 2004
Same old story? Do we need to modify our supportive care treatment of elderly cancer patients? Focus on antiemeticsCesare Gridelli
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 1, 2008
Treatment of advanced non small-cell lung cancer in the elderly: from best supportive care to the combination of platin-based chemotherapy and targeted therapiesCesare Gridelli
Current Opinion in Oncology|February 28, 2008
Targeted therapy developments in the treatment of non-small cell lung cancer: a promising but long and winding roadCesare Gridelli
Nature Reviews. Clinical Oncology|July 25, 2013
Lung cancer: Defining standard of care for performance status 2--don't rushCesare Gridelli
The Oncologist|January 18, 2007
The use of bisphosphonates in elderly cancer patientsCesare Gridelli
Nature Clinical Practice. Oncology|March 16, 2007
Does palliative chemotherapy beyond three courses benefit patients with non-small-cell lung cancer?Cesare Gridelli
Pageof 36